Table 1. Peptides used for the plaque-reduction assay.
Peptide name | Peptide sequence |
PB11–25A-Tat | MDVNPTLLFLKVPAQNAISTTFPYTYGRKKRRQRRRPP |
PB11–25AT6Y-Tat | MDVNPYLLFLKVPAQNAISTTFPYTYGRKKRRQRRRPP |
PX-Tat | LSNDELIKKLVTELAENSMIEAEEVYGRKKRRQRRRPP |
The underlined Y highlights the tyrosine residue derived from the PB1 FluB sequence. Bold letters in italics represent the HIV-Tat derived sequence that allow the peptides to cross the plasma membrane.